Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tominaga, M.
Right arrow Articles by Sekikawa, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tominaga, M.
Right arrow Articles by Sekikawa, A.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes Care, Vol 22, Issue 6 920-924, Copyright © 1999 by American Diabetes Association

ARTICLES

Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study

M Tominaga, H Eguchi, H Manaka, K Igarashi, T Kato and A Sekikawa
Department of Laboratory Medicine, Yamagata University School of Medicine, Japan. mtominag@med.id.yamagata-u.ac.jp

OBJECTIVE: To determine whether the new category of impaired fasting glucose (IFG) recently proposed by the Expert Committee of the American Diabetes Association is a risk factor for cardiovascular disease. RESEARCH DESIGN AND METHODS: Death certificates and residence transfer documents from the cohort population consisting of participants of the diabetes prevalence study in Funagata, Yamagata prefecture, Japan, 1990-1992, were analyzed up through the end of 1996. First, the cohort population was classified into three groups: normal glucose tolerance (NGT) (n = 2,016), impaired glucose tolerance (IGT) (n = 382), and diabetic (n = 253). Then the same population was reclassified into normal fasting glucose (NFG), IFG, and diabetic. The cumulative survival rates among the groups were compared using the classical life-table method, and age-adjusted analyses, the person-year method, and Cox's proportional hazard model were adopted. RESULTS: At the end of seven observed years, the cumulative survival rates from cardiovascular disease of IGT and diabetes were 0.962 and 0.954, respectively, both significantly lower than that of NGT (0.988). The Cox's proportional hazard model analysis showed that the hazard ratio of IGT to NGT on death from cardiovascular disease was 2.219 (95% CI 1.076-4.577). However, the cumulative survival rate of IFG from cardiovascular disease was 0.977, not significantly lower than that of NFG (0.985). The Cox's hazard ratio of IFG to NFG on death from cardiovascular disease was 1.136 (0.345-3.734), which was not significant either. CONCLUSIONS: IGT was a risk factor for cardiovascular disease, but IFG was not.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 JAMAHome page
J. Fuller
A 39-Year-Old Man With HIV-Associated Lipodystrophy
JAMA, September 3, 2008; 300(9): 1056 - 1066.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
Y. Doi, M. Kubo, K. Yonemoto, T. Ninomiya, M. Iwase, H. Arima, J. Hata, Y. Tanizaki, M. Iida, and Y. Kiyohara
Fasting Plasma Glucose Cutoff for Diagnosis of Diabetes in a Japanese Population
J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3425 - 3429.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes Spectr.Home page
C. Triplitt and C. A. Alvarez
Best Practices for Lowering the Risk of Cardiovascular Disease in Diabetes
Diabetes Spectr, July 1, 2008; 21(3): 177 - 189.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
H. W. Chan, C. Y. Cheung, Y. L. Liu, Y. H. Chan, H. S. Wong, W. L. Chak, K. S. Choi, K. F. Chau, and C. S. Li
Prevalence of abnormal glucose metabolism in Chinese renal transplant recipients: a single centre study
Nephrol. Dial. Transplant., May 8, 2008; (2008) gfn246v1.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
L. Xiang, J. Dearman, S. R. Abram, C. Carter, and R. L. Hester
Insulin resistance and impaired functional vasodilation in obese Zucker rats
Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1658 - H1666.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
R Kawasaki, J M Tielsch, J J Wang, T Y Wong, P Mitchell, Y Tano, M Tominaga, T Oizumi, M Daimon, T Kato, et al.
The metabolic syndrome and retinal microvascular signs in a Japanese population: the Funagata study
Br. J. Ophthalmol., February 1, 2008; 92(2): 161 - 166.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
Z. Milicevic, I. Raz, S. D. Beattie, B. N. Campaigne, S. Sarwat, E. Gromniak, I. Kowalska, E. Galic, M. Tan, and M. Hanefeld
Natural History of Cardiovascular Disease in Patients With Diabetes: Role of hyperglycemia
Diabetes Care, February 1, 2008; 31(Supplement_2): S155 - S160.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
C. Bianchi, R. Miccoli, G. Penno, and S. Del Prato
Primary Prevention of Cardiovascular Disease in People With Dysglycemia
Diabetes Care, February 1, 2008; 31(Supplement_2): S208 - S214.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
Y. S. Levitzky, M. J. Pencina, R. B. D'Agostino, J. B. Meigs, J. M. Murabito, R. S. Vasan, and C. S. Fox
Impact of Impaired Fasting Glucose on Cardiovascular Disease: The Framingham Heart Study
J. Am. Coll. Cardiol., January 22, 2008; 51(3): 264 - 270.
[Abstract] [Full Text] [PDF]

Home page
 British Journal of Diabetes & Vascular DiseaseHome page
R. Peter and A. Rees
Review: Postprandial glycaemia and cardiovascular risk
The British Journal of Diabetes & Vascular Disease, January 1, 2008; 8(1): 8 - 14.
[Abstract] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. E. S. Salley, E. P. Wickham, K. I. Cheang, P. A. Essah, N. W. Karjane, and J. E. Nestler
POSITION STATEMENT: Glucose Intolerance in Polycystic Ovary Syndrome A Position Statement of the Androgen Excess Society
J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4546 - 4556.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
E. L.M. Barr, P. Z. Zimmet, T. A. Welborn, D. Jolley, D. J. Magliano, D. W. Dunstan, A. J. Cameron, T. Dwyer, H. R. Taylor, A. M. Tonkin, et al.
Risk of Cardiovascular and All-Cause Mortality in Individuals With Diabetes Mellitus, Impaired Fasting Glucose, and Impaired Glucose Tolerance: The Australian Diabetes, Obesity, and Lifestyle Study (AusDiab)
Circulation, July 10, 2007; 116(2): 151 - 157.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
J. L. Kitzmiller, L. Dang-Kilduff, and M. M. Taslimi
Gestational Diabetes After Delivery: Short-term management and long-term risks
Diabetes Care, July 1, 2007; 30(Supplement_2): S225 - S235.
[Full Text] [PDF]

Home page
 Eur Heart J SupplHome page
Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. V. d. Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al.
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
Eur. Heart J. Suppl., June 1, 2007; 9(suppl_C): C3 - C74.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
D. M. Nathan, M. B. Davidson, R. A. DeFronzo, R. J. Heine, R. R. Henry, R. Pratley, and B. Zinman
Impaired Fasting Glucose and Impaired Glucose Tolerance: Implications for care
Diabetes Care, March 1, 2007; 30(3): 753 - 759.
[Full Text] [PDF]

Home page
 CJASNHome page
M. F. Crutchlow and R. D. Bloom
Transplant-Associated Hyperglycemia: A New Look at an Old Problem
Clin. J. Am. Soc. Nephrol., March 1, 2007; 2(2): 343 - 355.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
J. S. Pankow, D. K. Kwan, B. B. Duncan, M. I. Schmidt, D. J. Couper, S. Golden, and C. M. Ballantyne
Cardiometabolic Risk in Impaired Fasting Glucose and Impaired Glucose Tolerance: The Atherosclerosis Risk in Communities Study
Diabetes Care, February 1, 2007; 30(2): 325 - 331.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
J. M. Rijkelijkhuizen, G. Nijpels, R. J. Heine, L. M. Bouter, C. D.A. Stehouwer, and J. M. Dekker
High Risk of Cardiovascular Mortality in Individuals With Impaired Fasting Glucose Is Explained by Conversion to Diabetes: The Hoorn Study
Diabetes Care, February 1, 2007; 30(2): 332 - 336.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
M. J. Abrahamson
A 74-Year-Old Woman With Diabetes
JAMA, January 10, 2007; 297(2): 196 - 204.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. Van den Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al.
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
Eur. Heart J., January 1, 2007; 28(1): 88 - 136.
[Full Text] [PDF]

Home page
 HeartHome page
M Bartnik, L Ryden, K Malmberg, J Ohrvik, K Pyorala, E Standl, R Ferrari, M Simoons, J Soler-Soler, and on behalf of the Euro Heart Survey Investigators
Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease: a report from the Euro Heart Survey on Diabetes and the Heart
Heart, January 1, 2007; 93(1): 72 - 77.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
D.-Y. Hu, C.-Y. Pan, J.-M. Yu, and for the China Heart Survey Group
The relationship between coronary artery disease and abnormal glucose regulation in China: the China Heart Survey
Eur. Heart J., November 1, 2006; 27(21): 2573 - 2579.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
M. Ishihara, I. Inoue, T. Kawagoe, Y. Shimatani, S. Kurisu, T. Hata, Y. Nakama, Y. Kijima, and E. Kagawa
Is admission hyperglycaemia in non-diabetic patients with acute myocardial infarction a surrogate for previously undiagnosed abnormal glucose tolerance?
Eur. Heart J., October 2, 2006; 27(20): 2413 - 2419.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
S. Morita, S. Kasayama, M. Otsuki, N. Asanuma, H. Saito, M. Mukai, and M. Koga
Atherosclerotic risk factors in Japanese subjects with isolated impaired fasting glucose and those with isolated impaired glucose tolerance according to 1997 and 2003 american diabetes association criteria.
Diabetes Care, September 1, 2006; 29(9): 2123 - 2126.
[Full Text] [PDF]

Home page
 The Diabetes EducatorHome page
J. E. Gerich
Clinicians can help their patients control postprandial hyperglycemia as a means of reducing cardiovascular risk.
The Diabetes Educator, July 1, 2006; 32(4): 513 - 522.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
C. Nielson, T. Lange, and N. Hadjokas
Blood Glucose and Coronary Artery Disease in Nondiabetic Patients
Diabetes Care, May 1, 2006; 29(5): 998 - 1001.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
J. de Jager, J. M. Dekker, A. Kooy, P. J. Kostense, G. Nijpels, R. J. Heine, L. M. Bouter, and C. D.A. Stehouwer
Endothelial Dysfunction and Low-Grade Inflammation Explain Much of the Excess Cardiovascular Mortality in Individuals With Type 2 Diabetes: The Hoorn Study
Arterioscler. Thromb. Vasc. Biol., May 1, 2006; 26(5): 1086 - 1093.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
K. A. Armstrong, J. B. Prins, E. M. Beller, S. B. Campbell, C. M. Hawley, D. W. Johnson, and N. M. Isbel
Should an Oral Glucose Tolerance Test Be Performed Routinely in All Renal Transplant Recipients?
Clin. J. Am. Soc. Nephrol., January 1, 2006; 1(1): 100 - 108.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
H. Koyama, T. Shoji, H. Yokoyama, K. Motoyama, K. Mori, S. Fukumoto, M. Emoto, T. Shoji, H. Tamei, H. Matsuki, et al.
Plasma Level of Endogenous Secretory RAGE Is Associated With Components of the Metabolic Syndrome and Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., December 1, 2005; 25(12): 2587 - 2593.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
C. P. Wen, T. Y. D. Cheng, S. P. Tsai, H. L. Hsu, and S. L. Wang
Increased Mortality Risks of Pre-Diabetes (Impaired Fasting Glucose) in Taiwan
Diabetes Care, November 1, 2005; 28(11): 2756 - 2761.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
F. J. Novoa, M. Boronat, P. Saavedra, J. M. Diaz-Cremades, V. F. Varillas, F. La Roche, M. P. Alberiche, and A. Carrillo
Differences in Cardiovascular Risk Factors, Insulin Resistance, and Insulin Secretion in Individuals With Normal Glucose Tolerance and in Subjects With Impaired Glucose Regulation: The Telde Study
Diabetes Care, October 1, 2005; 28(10): 2388 - 2393.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
A. Teutonico, P. F. Schena, and S. Di Paolo
Glucose Metabolism in Renal Transplant Recipients: Effect of Calcineurin Inhibitor Withdrawal and Conversion to Sirolimus
J. Am. Soc. Nephrol., October 1, 2005; 16(10): 3128 - 3135.
[Abstract] [Full Text] [PDF]

Home page
 ANGIOLOGYHome page
A.-M. Salmasi and M. Dancy
The Glucose Tolerance Test, But Not HbA 1c, Remains the Gold Standard in Identifying Unrecognized Diabetes Mellitus and Impaired Glucose Tolerance in Hypertensive Subjects
Angiology, September 1, 2005; 56(5): 571 - 579.
[Abstract] [PDF]

Home page
 Diabetes CareHome page
Y. Kataoka, S. Yasuda, I. Morii, Y. Otsuka, A. Kawamura, and S. Miyazaki
Quantitative Coronary Angiographic Studies of Patients With Angina Pectoris and Impaired Glucose Tolerance
Diabetes Care, September 1, 2005; 28(9): 2217 - 2222.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
H Satoh, H Terada, A Uehara, H Katoh, M Matsunaga, K Yamazaki, F Matoh, and H Hayashi
Post-challenge hyperinsulinaemia rather than hyperglycaemia is associated with the severity of coronary artery disease in patients without a previous diagnosis of diabetes mellitus
Heart, June 1, 2005; 91(6): 731 - 736.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. S. Legro, C. L. Gnatuk, A. R. Kunselman, and A. Dunaif
Changes in Glucose Tolerance over Time in Women with Polycystic Ovary Syndrome: A Controlled Study
J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3236 - 3242.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
K. Hashimoto, K. Ikewaki, H. Yagi, H. Nagasawa, S. Imamoto, T. Shibata, and S. Mochizuki
Glucose Intolerance Is Common in Japanese Patients With Acute Coronary Syndrome Who Were Not Previously Diagnosed With Diabetes
Diabetes Care, May 1, 2005; 28(5): 1182 - 1186.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
Y. Doi, Y. Kiyohara, M. Kubo, Y. Tanizaki, K. Okubo, T. Ninomiya, M. Iwase, and M. Iida
Relationship Between C-Reactive Protein and Glucose Levels in Community-Dwelling Subjects Without Diabetes: The Hisayama Study
Diabetes Care, May 1, 2005; 28(5): 1211 - 1213.
[Full Text] [PDF]

Home page
 DiabetesHome page
The Diabetes Prevention Program Research Group
Intensive Lifestyle Intervention or Metformin on Inflammation and Coagulation in Participants With Impaired Glucose Tolerance
Diabetes, May 1, 2005; 54(5): 1566 - 1572.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. M. Choi, K. W. Lee, S. G. Kim, N. H. Kim, C. G. Park, H. S. Seo, D. J. Oh, D. S. Choi, and S. H. Baik
Inflammation, Insulin Resistance, and Glucose Intolerance in Acute Myocardial Infarction Patients without a Previous Diagnosis of Diabetes Mellitus
J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 175 - 180.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
C. Meyer, H. J. Woerle, J. M. Dostou, S. L. Welle, and J. E. Gerich
Abnormal renal, hepatic, and muscle glucose metabolism following glucose ingestion in type 2 diabetes
Am J Physiol Endocrinol Metab, December 1, 2004; 287(6): E1049 - E1056.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
E. B. Levitan, Y. Song, E. S. Ford, and S. Liu
Is Nondiabetic Hyperglycemia a Risk Factor for Cardiovascular Disease?: A Meta-analysis of Prospective Studies
Arch Intern Med, October 25, 2004; 164(19): 2147 - 2155.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
L. E. Robinson, S. Savani, D. S. Battram, D. H. McLaren, P. Sathasivam, and T. E. Graham
Caffeine Ingestion Before an Oral Glucose Tolerance Test Impairs Blood Glucose Management in Men with Type 2 Diabetes
J. Nutr., October 1, 2004; 134(10): 2528 - 2533.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
H. J. Woerle, W. P. Pimenta, C. Meyer, N. R. Gosmanov, E. Szoke, T. Szombathy, A. Mitrakou, and J. E. Gerich
Diagnostic and Therapeutic Implications of Relationships Between Fasting, 2-Hour Postchallenge Plasma Glucose and Hemoglobin A1c Values
Arch Intern Med, August 9, 2004; 164(15): 1627 - 1632.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
D. R. Blake, J. B. Meigs, D. C. Muller, S. S. Najjar, R. Andres, and D. M. Nathan
Impaired Glucose Tolerance, but not Impaired Fasting Glucose, Is Associated With Increased Levels of Coronary Heart Disease Risk Factors: Results From the Baltimore Longitudinal Study on Aging
Diabetes, August 1, 2004; 53(8): 2095 - 2100.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. Festa, R. D'Agostino Jr., A. J.G. Hanley, A. J. Karter, M. F. Saad, and S. M. Haffner
Differences in Insulin Resistance in Nondiabetic Subjects With Isolated Impaired Glucose Tolerance or Isolated Impaired Fasting Glucose
Diabetes, June 1, 2004; 53(6): 1549 - 1555.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
A. G. Smith and J. R. Singleton
The Diagnostic Yield of a Standardized Approach to Idiopathic Sensory-Predominant Neuropathy
Arch Intern Med, May 10, 2004; 164(9): 1021 - 1025.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
Z. T. Bloomgarden
Glycemic Treatment: Control of glycemia
Diabetes Care, May 1, 2004; 27(5): 1227 - 1234.
[Full Text] [PDF]

Home page
 HypertensionHome page
G. L. Bakris and J. R. Sowers
When Does New Onset Diabetes Resulting From Antihypertensive Therapy Increase Cardiovascular Risk
Hypertension, May 1, 2004; 43(5): 941 - 942.
[Full Text] [PDF]

Home page
 Clin. DiabetesHome page
J. B. Marks
Diabetes Potpourri: Nomenclature and Glycemia
Clin. Diabetes, April 1, 2004; 22(2): 50 - 51.
[Full Text] [PDF]

Home page
 Clin. DiabetesHome page
Expert Committee on the Diagnosis and Classificati
Follow-up Report on the Diagnosis of Diabetes Mellitus
Clin. Diabetes, April 1, 2004; 22(2): 71 - 79.
[Full Text] [PDF]

Home page
 Hum Mol GenetHome page
M. I. McCarthy
Progress in defining the molecular basis of type 2 diabetes mellitus through susceptibility-gene identification
Hum. Mol. Genet., April 1, 2004; 13(suppl_1): R33 - R41.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
M. J. Abrahamson
Optimal Glycemic Control in Type 2 Diabetes Mellitus: Fasting and Postprandial Glucose in Context
Arch Intern Med, March 8, 2004; 164(5): 486 - 491.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
J. A Davidson and A. Wilkinson
New-Onset Diabetes After Transplantation 2003 International Consensus Guidelines: An endocrinologist's view
Diabetes Care, March 1, 2004; 27(3): 805 - 812.
[Full Text] [PDF]

Home page
 Endocr. Rev.Home page
V. Fonseca, C. Desouza, S. Asnani, and I. Jialal
Nontraditional Risk Factors for Cardiovascular Disease in Diabetes
Endocr. Rev., February 1, 2004; 25(1): 153 - 175.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
O. Serri, C. Beauregard, and J. Hardy
Long-Term Biochemical Status and Disease-Related Morbidity in 53 Postoperative Patients with Acromegaly
J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 658 - 661.
[Abstract] [Full Text] [PDF]